Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cavalla

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
BMJ Supportive & Palliative Care|July 18, 2015
Specialist palliative care improves the quality of life in advanced neurodegenerative disorders: NE-PAL, a pilot randomised controlled studySimone Veronese, G Gallo, A Valle, et al.
Multiple Sclerosis International|April 18, 2015
Italian validation of the 12-item multiple sclerosis walking scaleC Solaro, E Trabucco, A Signori, et al.
Journal of Neuroimmunology|December 15, 2019
Kappa free light chains index in the differential diagnosis of Multiple Sclerosis from Neuromyelitis optica spectrum disorders and other immune-mediated central nervous system disordersP Cavalla, P Caropreso, S Limoncelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 6, 2013
Adverse events after endovascular treatment of chronic cerebro-spinal venous insufficiency (CCSVI) in patients with multiple sclerosisA Ghezzi, P Annovazzi, M P Amato, et al.
Journal of Neurology|July 22, 2021
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout durationD Ferraro, P Iaffaldano, T Guerra, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 20, 2016
Use of herbal remedies by multiple sclerosis patients: a nation-wide survey in ItalyA Loraschi, P Bellantonio, F Bortolon, et al.
Journal of Neurology|June 28, 2018
Two-year real-life efficacy, tolerability and safety of dimethyl fumarate in an Italian multicentre studyGiulia Mallucci, P Annovazzi, S Miante, et al.
Genes and Immunity|May 14, 2010
Progranulin gene variability increases the risk for primary progressive multiple sclerosis in malesC Fenoglio, D Scalabrini, F Esposito, et al.
Annals of Neurology|October 23, 2009
Real-life impact of early interferon beta therapy in relapsing multiple sclerosisM Trojano, F Pellegrini, D Paolicelli, et al.
Journal of the Neurological Sciences|April 10, 2021
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgiaD Ferraro, P Annovazzi, R Lanzillo, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
BMJ Supportive & Palliative Care|July 18, 2015
Specialist palliative care improves the quality of life in advanced neurodegenerative disorders: NE-PAL, a pilot randomised controlled studySimone Veronese, G Gallo, A Valle, et al.
Multiple Sclerosis International|April 18, 2015
Italian validation of the 12-item multiple sclerosis walking scaleC Solaro, E Trabucco, A Signori, et al.
Journal of Neuroimmunology|December 15, 2019
Kappa free light chains index in the differential diagnosis of Multiple Sclerosis from Neuromyelitis optica spectrum disorders and other immune-mediated central nervous system disordersP Cavalla, P Caropreso, S Limoncelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 6, 2013
Adverse events after endovascular treatment of chronic cerebro-spinal venous insufficiency (CCSVI) in patients with multiple sclerosisA Ghezzi, P Annovazzi, M P Amato, et al.
Journal of Neurology|July 22, 2021
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout durationD Ferraro, P Iaffaldano, T Guerra, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 20, 2016
Use of herbal remedies by multiple sclerosis patients: a nation-wide survey in ItalyA Loraschi, P Bellantonio, F Bortolon, et al.
Journal of Neurology|June 28, 2018
Two-year real-life efficacy, tolerability and safety of dimethyl fumarate in an Italian multicentre studyGiulia Mallucci, P Annovazzi, S Miante, et al.
Genes and Immunity|May 14, 2010
Progranulin gene variability increases the risk for primary progressive multiple sclerosis in malesC Fenoglio, D Scalabrini, F Esposito, et al.
Annals of Neurology|October 23, 2009
Real-life impact of early interferon beta therapy in relapsing multiple sclerosisM Trojano, F Pellegrini, D Paolicelli, et al.
Journal of the Neurological Sciences|April 10, 2021
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgiaD Ferraro, P Annovazzi, R Lanzillo, et al.
Pageof 6